Clinical effect of Diyu Shengbai Tablet on preventive treatment of leukopenia by IFN
- VernacularTitle:地榆升白片预防性治疗干扰素所致白细胞减少的临床观察
- Author:
Hongyun DONG
;
Yuqiang MI
;
Jing WANG
;
Wei CHEN
;
Xiliang WU
;
Chengzhen LU
- Publication Type:Journal Article
- Keywords:
Diyu Shengbai Tablet;
leukopenia;
interferon(IFN);
clinical observation
- From:
Chinese Traditional Patent Medicine
2010;(2):182-183
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To observe effect of Diyu Shengbai Tablet on preventive treatment for interferon-induced leu-kopenia. METHODS: One hundred and twelve patients with chronic hepatitis B treated by IFN were randomly as-signed into two groups, and they were respectively treated with Diyu Shengbai Tablet and Leucogen for 7 days before treatment by IFN. The leukocyte count of each group was done in 3 days,7 days, 10 days, 14 days,28 days after treatment by IFN. Comparison was made on the value of leukocytes between two preventive treatment groups. RE-SULTS: In the third day after treatment by IFN the value of ANC were(1.91±0.56)×10~9/L, (1.48±0.55)× 10~9/L respectively. The value of leukocytes were (3.91±0.33)×10~9/L, (3.16±0.49)×10~9/L respectively. They had the statistical difference (P<0.05). CONCLUSION: Diyu Shengbai Tablet has an effect on preventing lekopenia induced by IFN, and it is a safe, cheap and convenient drug to treat leucopenia by IFN.
